Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Jun 6, 2021 in Overactive bladder | 0 comments

In a nutshell

This study investigated the effectiveness of sacral neuromodulation (SNM) in patients with overactive bladder (OAB) that failed previous Botulinum toxin A (Botox; BTA) treatment. Researchers suggested that SNM is a good method in patients who failed first-line treatment.

Some background

OAB causes a sudden urge to urinate that is difficult to control. Patients need to urinate several times during the day and night. Leakage of urine might also be present, affecting the quality of life of these patients. This disorder is present in 11.8% to 16.6% of people from Europe and the US.  

The current standard treatment is behavioral therapy including bladder and pelvic muscle training with urine management. However, these treatments often fail due to an unsatisfactory response. In these cases, a new treatment such as Botulinum toxin A injections or SNM needs to be considered.

BTA injections into the bladder muscle improve the bladder movements that cause the OAB symptoms. When this treatment fails, it is recommended to switch to another line of treatment. The choice of treatment is made by the patient and the doctors.  

Another treatment option for OAB is SNM. During SNM a small electrode is placed near the sacral nerve (in the pelvis, controls bladder function). Electric impulses are sent to the nerve improving urinary function. Prior studies showed that this treatment significantly improved urinary symptoms. However, the effects of SNM in patients who underwent previous BTA injections are still not clear.

Methods & findings

This study included information about 263 patients with OAB. All patients received SNM treatment. Of these, 75 patients previously received BTA injections (group 1) and the rest did not have previous BTA treatment (group 2). Patients were followed up for an average of 40.7 months.

The success rate for SNM in group 1 was 66.7% and in group 2 was 72.9%. In group 1, the success rate after 2 injections or less was 68.5% and for 3 injections or more was 61.1%.

The bottom line

This study concluded that SNM is a good treatment method for patients with OAB bladder who failed prior BTA treatment.

The fine print

This study was based on medical records. Some information might have been incomplete. This might affect the results.

Published By :

Neurourology and urodynamics

Date :

Apr 08, 2021

Original Title :

Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients.

click here to get personalized updates